Clinical Trial Update: Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating sofosbuvir-containing regimens without interferon for acute hepatitis C infection, including participants with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection, Hepatitis | Phase 1 | Status: COMPLETED | Results posted: 2018-03-30